USPTO serial 79360579
LTZ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 2, 2024
- Examiner
- CLARK, MICHAEL J.
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LTZ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; drugs for medical purposes, namely, immunopotentiating drugs, immunosuppressive agents, medicines for tumor suppression; biochemical medicines for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; biological preparations for medical purposes for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; pharmaceutical preparations for treating cancers, neoplasms, autoimmune diseases, infectious diseases; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; immunostimulants; pre-filled syringes with pharmaceutical preparations for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases for medical purposes; injectable solutions in the nature of immunopotentiating drugs, immunosuppressive agents, medicines for tumor suppression for medical purposes; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shenzhen Zean Biomedical Co., Ltd.
- Other trademarks owned by LTZ Therapeutics Inc.
- Other trademarks owned by LTZ Therapeutics Inc.
- Other trademarks owned by LTZ Therapeutics Inc.
- Other trademarks in Class 005
- Similar marks named LTZ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 8, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 18, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 17, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 16, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 17, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 11, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 14, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 24, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 23, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2023 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Aug 1, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 31, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 19, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 24, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 19, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |